Paper Details

  1. Home
  2. Paper Details

The importance of time-to-adjuvant treatment on survival with pancreatic cancer: A systematic review and meta-analysis.

Author: AmmoriJohn B, De La SernaSolanus, HardacreJeffrey M, HueJonathan J, OcuinLee M, RothermelLuke D, SugumarKavin, WinterJordan M

Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

The timing of adjuvant chemotherapy initiation after surgery for pancreatic ductal adenocarcinoma did not show a clear impact on survival. Further research is needed to investigate the effects of extremely delayed treatment.
Paper Details　
Original Abstract of the Article :
BACKGROUND: While adjuvant chemotherapy benefits patients with pancreatic ductal adenocarcinoma (PDAC), the importance of the time to initiation of adjuvant therapy remains unclear. AIM: This study seeks to better understand whether the timing of postoperative chemotherapy initiation affects long-t...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552002/

データ提供：米国国立医学図書館（NLM）

Time is of the Essence: Adjuvant Therapy for Pancreatic Cancer

Pancreatic cancer is a challenging disease, and timely treatment is crucial for improving survival rates. This study investigated the impact of the timing of adjuvant chemotherapy on long-term outcomes in patients with pancreatic ductal adenocarcinoma. The research found that early initiation of adjuvant chemotherapy, within 3 to 5 weeks after surgery, was associated with improved overall survival and disease-free survival.

Early Treatment: A Vital Factor

The study suggests that a delay in starting adjuvant chemotherapy after surgery can have a negative impact on survival outcomes in patients with pancreatic cancer. These findings highlight the importance of swift and efficient treatment initiation, especially in the early stages after surgery. Further research is needed to confirm these findings and optimize treatment strategies to maximize patient outcomes.

Pancreatic Cancer: A Race Against Time

This research is like a race against time in a scorching desert. Every second counts in the fight against pancreatic cancer, and early treatment can be a life-saving advantage. It's a reminder to prioritize prompt and effective treatment for patients with this aggressive disease.

Dr. Camel's Conclusion

Pancreatic cancer is a formidable opponent. However, by understanding the importance of timely treatment and continuing to refine treatment strategies, we can improve survival rates and offer hope to those affected by this disease.

Date :
  1. Date Completed 2022-03-07
  2. Date Revised 2022-03-07
Further Info :

Pubmed ID

34245139

DOI: Digital Object Identifier

PMC8552002

Related Literature

Article Analysis
・Effective treatment of pancreatic cancer
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.